Search Results

There are 18700 results for: content related to: The prescription drug epidemic in the United States: A perfect storm

  1. Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”?

    The American Journal on Addictions

    Volume 16, Issue 3, May-June 2007, Pages: 166–173, Lauretta E. Grau PhD, Nabarun Dasgupta MPH, Alison Phinney Harvey MPH, Kevin Irwin MA, Anthony Givens, Mark L. Kinzly and Robert Heimer PhD

    Version of Record online : 19 APR 2010, DOI: 10.1080/10550490701375293

  2. AAPM 2015 ANNUAL MEETING ABSTRACTS

    Pain Medicine

    Volume 16, Issue 3, March 2015, Pages: 558–622,

    Version of Record online : 19 MAR 2015, DOI: 10.1111/pme.12696

  3. Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program

    Pharmacoepidemiology and Drug Safety

    Suzanne K. Vosburg, Colleen Haynes, Andrea Besharat and Jody L. Green

    Version of Record online : 27 JUN 2017, DOI: 10.1002/pds.4248

  4. Impact of abuse-deterrent OxyContin on prescription opioid utilization

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 197–204, Catherine S. Hwang, Hsien-Yen Chang and G. Caleb Alexander

    Version of Record online : 13 NOV 2014, DOI: 10.1002/pds.3723

  5. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis

    Addiction

    Volume 107, Issue 3, March 2012, Pages: 587–596, April M. Young and Jennifer R. Havens

    Version of Record online : 26 OCT 2011, DOI: 10.1111/j.1360-0443.2011.03635.x

  6. FROM WHITE BULLETS TO BLACK MARKETS AND GREENED MEDICINE: THE NEUROECONOMICS AND NEURORACIAL POLITICS OF OPIOID PHARMACEUTICALS

    Annals of Anthropological Practice

    Volume 36, Issue 1, May 2012, Pages: 167–182, Helena Hansen and Mary E. Skinner

    Version of Record online : 19 SEP 2012, DOI: 10.1111/j.2153-9588.2012.01098.x

  7. Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers

    The Journal of Clinical Pharmacology

    Volume 52, Issue 4, April 2012, Pages: 600–606, Dr M. R. Lofwall, Dr D. E. Moody, Dr W. B. Fang, Mr. P. A. Nuzzo and Dr S. L. Walsh

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011401620

  8. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol

    Addiction

    Volume 110, Issue 2, February 2015, Pages: 226–237, Louisa Degenhardt, Briony Larance, Raimondo Bruno, Nicholas Lintzeris, Robert Ali and Michael Farrell

    Version of Record online : 30 OCT 2014, DOI: 10.1111/add.12746

  9. You have full text access to this OnlineOpen article
    The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting

    Clinical Pharmacology & Therapeutics

    Volume 100, Issue 3, September 2016, Pages: 275–286, PM Coplan, HD Chilcoat, SF Butler, EM Sellers, A Kadakia, V Harikrishnan, JD Haddox and RC Dart

    Version of Record online : 22 JUN 2016, DOI: 10.1002/cpt.390

  10. Challenges in the Federal Regulation of Pain Management Technologies

    The Journal of Law, Medicine & Ethics

    Volume 31, Issue 1, March 2003, Pages: 55–74, Lars Noah

    Version of Record online : 24 JAN 2007, DOI: 10.1111/j.1748-720X.2003.tb00059.x

  11. Oxycodone Abuse in New York City: Characteristics of Intravenous and Intranasal Users

    The American Journal on Addictions

    Volume 20, Issue 3, May-June 2011, Pages: 190–195, Jermaine D. Jones, Suzanne K. Vosburg, Jeanne M. Manubay and Sandra D. Comer

    Version of Record online : 8 MAR 2011, DOI: 10.1111/j.1521-0391.2011.00120.x

  12. FDA approves OxyContin for certain pediatric patients

    Alcoholism & Drug Abuse Weekly

    Volume 27, Issue 36, 21 September 2015, Pages: 4–5, Alison Knopf

    Version of Record online : 21 SEP 2015, DOI: 10.1002/adaw.30322

  13. Anticipated and unanticipated consequences of abuse deterrent formulations of opioid analgesics

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 205–207, Theodore J. Cicero and Matthew S. Ellis

    Version of Record online : 16 DEC 2014, DOI: 10.1002/pds.3732

  14. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada

    Drug and Alcohol Review

    Volume 32, Issue 3, May 2013, Pages: 276–287, Benedikt Fischer, Anca Ialomiteanu, Angela Boak, Edward Adlaf, Jürgen Rehm and Robert E. Mann

    Version of Record online : 11 JAN 2013, DOI: 10.1111/dar.12025

  15. Prescription Drug Abuse: Insight Into the Epidemic

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 3, September 2010, Pages: 307–317, S H Hernandez and L S Nelson

    Version of Record online : 4 AUG 2010, DOI: 10.1038/clpt.2010.154

  16. You have free access to this content
    Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue S1, September 2015, Pages: 1–587,

    Version of Record online : 25 SEP 2015, DOI: 10.1002/pds.3838

  17. You have full text access to this OnlineOpen article
    Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties

    Pain Medicine

    Volume 16, Issue 11, November 2015, Pages: 2142–2151, Jeff Gudin, Naama Levy-Cooperman, Ernest A. Kopecky and Alison B. Fleming

    Version of Record online : 22 JUN 2015, DOI: 10.1111/pme.12834

  18. You have full text access to this OnlineOpen article
    Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 12, December 2014, Pages: 1238–1246, Nelson E. Sessler, Jerod M. Downing, Hrishikesh Kale, Howard D. Chilcoat, Todd F. Baumgartner and Paul M. Coplan

    Version of Record online : 11 JUN 2014, DOI: 10.1002/pds.3658

  19. You have free access to this content
    Abstracts

    Drug and Alcohol Review

    Volume 33, Issue S1, November 2014, Pages: 1–67,

    Version of Record online : 10 NOV 2014, DOI: 10.1111/dar.12222

  20. You have free access to this content
    Abstract

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue S2, August 2017, Pages: 3–636,

    Version of Record online : 22 AUG 2017, DOI: 10.1002/pds.4275